BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

MRI Interventions, Inc. (MRIC) Goes Public


5/23/2012 7:59:24 AM

Memphis Business Journal by Michael Sheffield, Staff writer

Memphis company MRI Interventions officially launched its initial public offering this week.

The company makes and markets a minimally invasive neurosurgical system called ClearPoint, which uses MRI scanners to pinpoint designated areas in the brain for surgery. The device enables surgeons to perform surgeries while patients are in MRI scanners.

ClearPoint can be used for treatment of neurological disorders ranging from Parkinson’s disease and epilepsy to brain tumors, and possibly Alzheimer’s. Its stock was priced at $1 Tuesday and is trading Over the Counter. The ticker symbol is MRIC.

MRI Interventions sells the surgical hardware, which includes a workstation monitor, imaging coil and fixation frame (which keeps the patient stationary during surgery) for about $180,000, as well as “disposable” products that include a hand controller for surgical tools, a frame that holds and guides the tools and a “smart grid” for surgical entry planning for $7,300.

The company currently has ClearPoint running in 15 hospitals around the U.S., including Cincinnati Children’s Hospital, Memorial Sloan-Kettering Cancer Center in New York and hospitals in Baltimore, Cleveland and New Haven, Conn.

The company had revenue of $1.5 million in 2012, and had revenue of nearly $1 million through the first quarter of 2012, according to a filing with the U.S. Securities and Exchange Commission.

While the company doesn’t have ClearPoint in any local hospitals, company CEO Kimble Jenkins said that could change as the products become more well known. There are more than 4,500 MRI machines in use in hospitals across the country, and each one, Jenkins said, could be used with ClearPoint.

“From an operational perspective, we’ve got a technology we believe is industry changing,” Jenkins said. “We thought it was time to go public and generate a broader awareness of the company.”

The company is also developing a similar product for use in cardiac surgeries called ClearTrace, which could be launched in the next two years, Jenkins said.

MRI Interventions currently employs 20 people, with its four-person executive team based in Memphis. The company’s products are developed and manufactured in Irvine, Calif. Previously known as SurgiVision Inc., the company was founded in 1998.



Read at News Release
Read at News Release

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES